2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of 2-methoxyestradiol in treating patients who have
advanced solid tumors. 2-methoxyestradiol may stop or slow the growth of solid tumors by
stopping blood flow to the tumor